Skip to content
Menu

ICU Medical, Inc. ICUI

Full chart Compare
Set alert

Price alert · ICUI

All alert types
172.52 USD -3.24 (-1.84%)

Regular-session close

172.52 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

171.40 Day range 178.52
113.37 52-week range 192.85
YTD
+20.92%
1 year
+28.43%

5D -3.61 (-2.02%)

175180FriMonTueWedThu175.39
Market cap
4.31B
Revenue (ttm)
2.18B
Profit margin
2.76%
EPS (ttm)
2.39
Shares out
25.01M
P/E ratio
72.18
Forward P/E
17.83
YTD return
+20.92%
1-year return
+28.43%
50-day average
165.05
Volume
223.43K
Avg volume
252.56K
Open
177.17
Previous close
175.76
Day's range
171.40 – 178.52
52-week range
113.37 – 192.85
Beta
0.88
Analysts
Buy
Price target
194.25 (+12.6%)
Earnings date
Feb 18, 2027

Key statistics

200-day average
150.15
Enterprise value
5.30B
PEG ratio
0.09
Price / sales
1.98
Price / book
1.97
Revenue growth
4.40%
Free cash flow
214.88M
Total cash
307.88M
Total debt
1.21B
Return on equity
2.79%
Short % of float
8.00%

Fundamental scorecard

10 of 25 checks passed on ICUI’s reported financials

ValueGrowthProfitabilityHealthDividend

10of 25 checks passed

  • Value 1 of 5
  • Growth 3 of 5
  • Profitability 3 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
ICUI Revenue — quarterly 560.44M
ICUI Net income — quarterly 26.85M
ICUI EPS — quarterly 1.07

Earnings

ICUI recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 18, 2027Dec 30, 20262.15———
Nov 5, 2026Sep 30, 20262.142.44+0.30+14.02%
Aug 6, 2026Jun 30, 20261.912.37+0.46+24.08%
May 7, 2026Mar 31, 20261.781.97+0.19+10.67%
Feb 19, 2026Dec 31, 20251.681.91+0.23+13.69%
Nov 6, 2025Sep 30, 20251.432.03+0.60+41.96%

Upgrades / downgrades

ICUI analyst upgrades and downgrades
DateFirmActionFromTo
Nov 6, 2026KeybancmainOverweightOverweight
Nov 6, 2026Piper SandlermainOverweightOverweight
Aug 7, 2026Piper SandlermainOverweightOverweight
Aug 7, 2026BTIGmainBuyBuy
Aug 7, 2026NeedhammainBuyBuy
Aug 7, 2026KeybancmainOverweightOverweight

About ICU Medical, Inc.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
icumed.com

News

Your note

Sign in to keep a note on ICUI — it syncs with the Stock Master app.

Insider holders

ICUI insider holders
InsiderRelationLatest transactionDateShares held
ABBEY DONALD MDirectorConversion of Exercise of derivative securityMay 12, 20266,004
BONNELL BRIAN MICHAELChief Financial OfficerSaleAug 31, 202656,062
FINNEY ELISHA WDirectorSaleNov 12, 20264,871
GREENBERG DAVID CDirectorConversion of Exercise of derivative securityMay 12, 20269,214
HERNANDEZ LAURIEDirectorConversion of Exercise of derivative securityMay 12, 20264,862
HOFFMEISTER DAVID FDirectorConversion of Exercise of derivative securityMay 12, 20266,004

Institution ownership

ICUI institution ownership
Holder% heldSharesValueReported
Blackrock Inc.14.96%3,741,395645.47MSep 29, 2026
Janus Henderson Group Ltd.11.02%2,756,846475.61MSep 29, 2026
Vanguard Portfolio Management LLC5.86%1,466,300252.97MSep 29, 2026
Vanguard Capital Management LLC4.49%1,123,828193.88MSep 29, 2026
Dimensional Fund Advisors LP4.38%1,096,314189.14MSep 29, 2026
Fuller & Thaler Asset Management Inc.4.34%1,085,944187.35MSep 29, 2026

Fund ownership

ICUI fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%1,489,253256.93MSep 29, 2026
JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund4.92%1,230,753212.33MSep 29, 2026
UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd.4.22%1,054,324181.89MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%791,929136.62MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.56%641,126110.61MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.29%573,52298.94MJun 29, 2026